Argen X SE

Research Argen X SE (ARGX) on Bullrun: market cap USD 56.74B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerARGX
• ExchangeNASDAQ
• CountryNetherlands
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 56.74B
• Financial periodQ1 2026
• RevenueUSD 1.30B
• Net incomeUSD 366.00M
• Gross margin90.7%

Valuation Snapshot

latest market cap is USD 56.74B.

About Argen X SE

argenx SE, a commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally. The company offers VYVGART for the treatment of gMG and immune thrombocytopenia (ITP), and VYVGART HYTRULO for the treatment of gMG and chronic inflammatory demyelinating polyneuropathy (CIDP).

Frequently asked questions

What is Argen X SE's market cap?

Argen X SE's market capitalization is USD 56.74B.

What does Argen X SE do?

argenx SE, a commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.